Clinical Trials Browser

Urinary Bladder Neoplasms

Prostatic Neoplasms

Sarcoma, Ichthyosis, X-Linked

Pancreatic Neoplasms

Breast Neoplasms, Neoplasm Metastasis, Recurrence

Peripheral Nervous System Diseases

Smoldering Multiple Myeloma, Neoplasms, Plasma Cell

Multiple Myeloma

Glioblastoma, Glioma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

Brain Neoplasms, Glioblastoma, Glioma

Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Disease Progression

Glioblastoma

Pancreatic Neoplasms, Carcinoma, Endometrioid

Depression, Fallopian Tube Neoplasms, Ovarian Neoplasms

Brain Neoplasms

Brain Neoplasms, Glioblastoma, Glioma, Lymphoma, Follicular

Diffuse Intrinsic Pontine Glioma, Neuroblastoma

Lung Neoplasms

Brain Neoplasms, Glioblastoma

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Brain Neoplasms, Oligodendroglioma

Brain Neoplasms, Glioblastoma

Mesothelioma, Malignant

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell

Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Ependymoma, Glioblastoma, Medulloblastoma, Meningeal Carcinomatosis

Cholangiocarcinoma

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Lung Neoplasms

Multiple Myeloma

Multiple Myeloma

Astrocytoma, Brain Neoplasms, Disease, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Ganglioglioma

Small Cell Lung Carcinoma

Prostatic Neoplasms

Leukemia, Myeloid, Acute

Colonic Neoplasms, Colorectal Neoplasms

Melanoma, Skin Neoplasms

Metastatic Castration-resistant Prostate Cancer

Lymphoma, Non-Hodgkin

Breast Neoplasms

Prostatic Neoplasms

Advanced Melanoma

Multiple Myeloma

Clinical Trials

A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer

EX-CIPN

T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM

A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma

PNOC017

COAXIN

IMPACT

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

FRAME

Depression Treatment and Screening in Ovarian Cancer Patients

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Neoadjuvant Atezolizumab in Cutaneous Melanoma

PNOC020

PEACH

MAGELLAN

IMPACT

Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine

ADAGiO

RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer

Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma

BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma

rQNestin

COSINR

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia

Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer

XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma

Rad2Nivo

AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma

Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

BaseTIL-03M

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment